Marie Elisabeth Wahren Herlenius

Professor

Academic article

Show author(s) (2023). Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open. 21 pages.
Show author(s) (2023). Skin infiltrating NK cells in cutaneous T-cell lymphoma are increased in number and display phenotypic alterations partially driven by the tumor. Frontiers in Immunology.
Show author(s) (2023). Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies. EBioMedicine. 12 pages.
Show author(s) (2023). Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies. Journal of Autoimmunity. 14 pages.
Show author(s) (2023). Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open. 19 pages.
Show author(s) (2023). 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice. Annals of the Rheumatic Diseases. 754-762.

Show author(s) (2022). Strong association of combined genetic deficiencies in the classical complement pathway with risk of systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis & Rheumatology. 1842-1850.
Show author(s) (2022). Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases. Arthritis & Rheumatology. 1440-1450.
Show author(s) (2022). Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function. Annals of the Rheumatic Diseases. 1151-1161.

Show author(s) (2021). SOCS3 Expression by Thymic Stromal Cells Is Required for Normal T Cell Development. Frontiers in Immunology. 17 pages.
Show author(s) (2021). Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block. Annals of the Rheumatic Diseases. 194-202.
Show author(s) (2021). Interferons and innate immune activation in autoimmune congenital heart block. Scandinavian Journal of Immunology.
Show author(s) (2021). Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment. Rheumatology. 1445-1455.

Show author(s) (2020). Cigarette smoking patterns preceding primary Sjögren's syndrome. RMD Open. 1-9.

Academic literature review

Show author(s) (2023). Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies. Nature Reviews Rheumatology. 288-306.

Article in business/trade/industry journal

Show author(s) (2022). Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 979-989.

Research groups